Waters Corporation (WAT)

NYQ – Real Time Price. Currency in USD

415.59

+0.59 (0.14%)

Market open: Aug 12, 2026, 2:07 PM EDT

414.59

-0.41 (-0.10%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

09.08.2026

Waters Q2 Earnings Call Highlights

Waters NYSE: WAT reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic Solutions businesses. The company raised its full-year outlook for organic revenue, acquired-business revenue and adjusted earnings per share after results exceeded its prior guidance.

05.08.2026

Waters Q2 Earnings Beat Estimates, 2026 Revenue Growth View Raised

WAT tops Q2 estimates, raises its 2026 outlook and posts broad-based growth across organic and acquired businesses.

04.08.2026

Waters Corporation (WAT) Q2 2026 Earnings Call Transcript

04.08.2026

Waters (WAT) Q2 Earnings and Revenues Beat Estimates

Waters (WAT) came out with quarterly earnings of $3.05 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.95 per share a year ago.

04.08.2026

Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

Second Quarter 2026 Highlights Total reported revenue of $1.645 billion surpassed the high end of the guidance range, driven by broad-based outperformance across both organic revenue and the acquired businesses. Organic revenue of $828 million grew 7% as reported and 9% in constant currency; the Analytical Sciences Division (ASD) delivered 8% instrument growth and double-digit chemistry consumables growth, led by low-double-digit growth in both Pharma and A&G end markets, in constant currency, as the market recovery has entered a broader phase, expanding across additional customer segments.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
WAT	TD Cowen	Buy	undefined >> $475	August 5th 2026

Press releases

04.08.2026

Waters Corporation (WAT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us